Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Vitalhub ( (TSE:VHI) ) has shared an announcement.
VitalHub reported significant financial growth in the second quarter of 2025, with annual recurring revenue up 55% year-over-year to $79.6 million and total revenue up 47% to $23.9 million. The company has successfully integrated its 2024 acquisitions, including Novari and Induction, enhancing its patient flow solutions and expanding its international presence. With over $40 million in cash and more than $90 million in ARR, VitalHub is well-positioned for continued expansion.
The most recent analyst rating on (TSE:VHI) stock is a Buy with a C$10.50 price target. To see the full list of analyst forecasts on Vitalhub stock, see the TSE:VHI Stock Forecast page.
Spark’s Take on TSE:VHI Stock
According to Spark, TipRanks’ AI Analyst, TSE:VHI is a Outperform.
Vitalhub’s strong financial performance and strategic acquisitions significantly enhance its growth potential and market positioning. While technical indicators show bullish trends, high valuation metrics suggest caution. The absence of earnings call data limits insight into management’s future guidance.
To see Spark’s full report on TSE:VHI stock, click here.
More about Vitalhub
VitalHub is a leading software company that empowers health and human services providers globally. Its comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions, serving over 1,000 clients across the UK, Canada, and other regions.
Average Trading Volume: 141,809
Technical Sentiment Signal: Buy
Current Market Cap: C$750M
See more insights into VHI stock on TipRanks’ Stock Analysis page.